Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRI | Common Stock | Options Exercise | $130K | +1.55K | +17.34% | $83.84 | 10.5K | May 6, 2021 | Direct | |
transaction | CRI | Common Stock | Sale | -$220K | -2.02K | -19.24% | $109.10 | 8.48K | May 6, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRI | Employee Stock Option (Right to Purchase) | Options Exercise | $0 | -1.55K | -100% | $0.00* | 0 | May 6, 2021 | Common Stock | 1.55K | $83.84 | Direct | F3 |
Id | Content |
---|---|
F1 | This is a weighted average price. The shares were sold in multiple trade executions at prices ranging from $109.04 to $109.12 inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. |
F2 | Some of these shares are restricted shares that are subject to either time-vesting or performance-based restrictions. |
F3 | These time-vesting options are exercisable in four equal annual installments beginning one year from the grant date. |